Pharmaceutical company Actavis plc, based in Ireland, announced Tuesday it has completed the acquisition of Warner Chilcott plc in a stock-for-stock transaction valued at approximately $8.5 billion. Warner Chilcott has a plant in Fajardo.
Pharma-Bio Serv., a global compliance and validation services consulting solutions provider based in Dorado, announced net revenues for the three and six months ended April 30, 2013 of $8.3 and $15.9 million, an increase of approximately $1.2 and $2.5 million, or 17 percent and 18 percent, respectively, when compared to the same periods last year.
Bristol-Myers Squibb Company today broke ground on a $200 million expansion of its facility in Humacao to add manufacturing capacity that will prepare the plant for the production of additional medicines. The project is expected to create 100 full-time jobs at the facility over time.
Merck’s pharmaceutical operations in Puerto Rico are ramping up their production capacity with the recent addition of Liptruzet cholesterol inhibiting tablets, which are being manufactured in Las Piedras, Andrew Wirths, general manager of the company on the island, said Wednesday.
Less than four months after confirming plans to pick up the assets of the former Pfizer manufacturing plant in Caguas, Neolpharma officially inaugurated Tuesday its first operation on U.S. soil and the second established outside its native Mexico.
The Puerto Rico Justice Department has joined 19 other U.S. jurisdictions in an antitrust case filed by the Federal Trade Commission aimed at fighting monopolistic practices within the pharmaceutical industry that reportedly cost consumers about $3.5 billion per year in the form of higher drug prices.
The biopharmaceutical industry is a major driver of Puerto Rico’s social and economic development, not just for the 86,000 direct and indirect jobs its creates, but for the multiplier effects it has upon other sectors.
The Puerto Rico Pharmaceutical Industry Association is lobbying for giving island patients broader access to innovative drugs and treatments, and against the final decision being made by anyone other than the prescribing physician.
International events organizer Reed Exhibitions will be producing the 6th edition of its Interphex Puerto Rico convention on Oct. 4-5, when it expects to bring together the island’s most important life sciences companies and suppliers at the Puerto Rico Convention Center.
Merck Puerto Rico announced it will invest some $80 million over the next year to expand production capabilities at its Las Piedras manufacturing plant.
More than two years after running into some serious production troubles at its Las Piedras plant, McNeil Consumer Healthcare announced Tuesday it will layoff 225 people as it focuses on complying with correcting deficiencies detected by the U.S. Food and Drug Administration.
Bristol-Myers Squibb Company announced a $165 million expansion of its facility in Humacao to add manufacturing capacity that will prepare the plant for the production of additional medicines.
German pharmaceutical Sartorius Stedim Biotech inaugurated Tuesday its new $20 million expansion at its Yauco plant, completed some 14 months after it announced plans to increase its presence in Puerto Rico.
Interphex Puerto Rico, the annual event that gathers key components of the island’s knowledge-based economy, will again offer an agenda full of conferences and training sessions Oct. 20-21 that focus on its mission to generate activity and help professionals move forward.
The Puerto Rico Pharmaceutical Industry Association raised three specific objections to the recently released study evaluating quality results in drug manufacturing plants outside the U.S. mainland, saying, among other things, the findings were “highly questionable.”
A Dow Jones/Factiva content provider since 2014
Subscribe to our Dollars & Sense podcast!
NIMB ON SOCIAL MEDIA